H

Helen Rizos

Macquarie University

ORCID: 0000-0002-2094-9198

Publishes on Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses. 372 papers and 12.1k citations.

PubIndex Score98Top 2%How it's scored

372Publications

12.1kTotal Citations

First publication: 1989First senior author: 2005

Melanoma and MAPK Pathways Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Cutaneous Melanoma Detection and Management CAR-T cell therapy research

Top publicationsby citations

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma

Georgina V. Long, Helen Rizos|Nature Communications|2014

Cited by 385

Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma

Oskar Marín-Béjar, Jean‐Christophe Marine, Aljosja Rogiers et al.|Cancer Cell|2021

Cited by 154

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma

Su Yin Lim, Helen Rizos|Nature Communications|2023

Cited by 127

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma

Georgina V. Long, Helen Rizos|Nature Medicine|2025

Cited by 55

Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy

Wei Yen Chan, Helen Rizos, Jenny Lee et al.|Journal of Experimental & Clinical Cancer Research|2024

Cited by 22